{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:14:40Z","timestamp":1792034080956,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501933"],"award-info":[{"award-number":["81501933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY17H060009"],"award-info":[{"award-number":["LY17H060009"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.intimp.2017.06.017","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T21:17:35Z","timestamp":1498598255000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Cryptotanshinone protects against IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice"],"prefix":"10.1016","volume":"50","author":[{"given":"Zhenhua","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2017.06.017_bb0005","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee","volume":"43","author":"Gamble","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2017.06.017_bb0010","article-title":"The spatial organisation of joint surface chondrocytes: review of its potential roles in tissue functioning, disease and early, preclinical diagnosis of osteoarthritis","author":"Aicher","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1242\/dmm.016881","article-title":"Targets, models and challenges in osteoarthritis research","volume":"8","author":"Thysen","year":"2015","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keh344","article-title":"Osteoarthritis, angiogenesis and inflammation","volume":"44","author":"Bonnet","year":"2005","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.20776","article-title":"Role of interleukin-1 and tumor necrosis factor \u03b1 in matrix degradation of human osteoarthritic cartilage","volume":"52","author":"Kobayashi","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.intimp.2017.06.017_bb0030","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/art.38657","article-title":"Induction of an inflammatory and prodegradative phenotype in autologous fibroblast-like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis","volume":"66","author":"Eymard","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2017.06.017_bb0035","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11999-013-3235-9","article-title":"Elevation of serum tumor necrosis factor \u03b1 in patients with periprosthetic osteolysis: a case-control study","volume":"472","author":"Chaganti","year":"2014","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"6","key":"10.1016\/j.intimp.2017.06.017_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11926-000-0021-y","article-title":"Osteoarthritis and cartilage: the role of cytokines","volume":"2","author":"Goldring","year":"2000","journal-title":"Curr. Rheumatol. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2017.06.017_bb0045","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3899\/jrheum.080346","article-title":"The interleukin 1\u03b2 pathway in the pathogenesis of osteoarthritis","volume":"35","author":"Daheshia","year":"2008","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2017.06.017_bb0050","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/rheumatology\/keu254","article-title":"Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation","volume":"53","author":"Xue","year":"2014","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.intimp.2017.06.017_bb0055","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1271\/bbb.63.2236","article-title":"Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge","volume":"63","author":"Dong-Sun","year":"1999","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"11","key":"10.1016\/j.intimp.2017.06.017_bb0060","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.intimp.2011.07.018","article-title":"Cryptotanshinone inhibits LPS-induced proinflammatory mediators via TLR4 and TAK1 signaling pathway","volume":"11","author":"Li","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2017.06.017_bb0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/1940-6207.CAPR-11-0551","article-title":"Cryptotanshinone activates p38\/JNK and inhibits Erk1\/2 leading to caspase-independent cell death in tumor cells","volume":"5","author":"Chen","year":"2012","journal-title":"Cancer Prev. Res."},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2010.06.006","article-title":"Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas (APO1\/CD95)-mediated apoptosis through Bcl-2 and MAPK regulation","volume":"298","author":"Park","year":"2010","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.intimp.2017.06.017_bb0075","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1016\/j.bmcl.2011.09.112","article-title":"Ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide","volume":"21","author":"Soares","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.intimp.2017.06.017_bb0080","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.fct.2007.04.005","article-title":"PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation","volume":"45","author":"Park","year":"2007","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.intimp.2017.06.017_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4196\/kjpp.2016.20.4.347","article-title":"Cryptotanshinone inhibits TNF-\u03b1-induced LOX-1 expression by suppressing reactive oxygen species (ROS) formation in endothelial cells","volume":"20","author":"Ran","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2017.06.017_bb0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.trsl.2014.12.004","article-title":"Therapeutic effect of Cryptotanshinone on collagen-induced arthritis in rats via inhibiting nuclear factor kappa B signaling pathway","volume":"165","author":"Wang","year":"2015","journal-title":"Transl. Res."},{"issue":"8","key":"10.1016\/j.intimp.2017.06.017_bb0095","first-page":"12617","article-title":"Effects of cryptotanshinone on the expression levels of inflammatory factors in myocardial cells caused by Ang II and its mechanism","volume":"8","author":"Tang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2017.06.017_bb0100","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.joca.2007.07.009","article-title":"Avocado soybean unsaponifiables (ASU) suppress TNF-\u03b1, IL-1\u03b2, COX-2, iNOS gene expression, and prostaglandin E 2 and nitric oxide production in articular chondrocytes and monocyte\/macrophages","volume":"15","author":"Au","year":"2007","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2017.06.017_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"8 Suppl","key":"10.1016\/j.intimp.2017.06.017_bb0115","first-page":"S236","article-title":"Practical considerations for the pharmacologic management of osteoarthritis","volume":"15","author":"Altman","year":"2009","journal-title":"Am. J. Manag. Care"},{"issue":"11","key":"10.1016\/j.intimp.2017.06.017_bb0120","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.arthro.2005.08.034","article-title":"Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament\u2013deficient knee","volume":"21","author":"Marks","year":"2005","journal-title":"Arthroscopy"},{"issue":"8","key":"10.1016\/j.intimp.2017.06.017_bb0125","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.0911377107","article-title":"LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2017.06.017_bb0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/oxfordjournals.jbchem.a021955","article-title":"Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes","volume":"123","author":"Sasaki","year":"1998","journal-title":"J. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2017.06.017_bb0135","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y","article-title":"Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis","volume":"41","author":"Hashimoto","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2017.06.017_bb0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12272-001-1223-4","article-title":"Inhibition of prostaglandin and nitric oxide production in lipopolysaccharide-treated RAW 264.7 cells by tanshinones from the roots of Salvia miltiorrhiza bunge","volume":"31","author":"Jeon","year":"2008","journal-title":"Arch. Pharm. Res."},{"issue":"2","key":"10.1016\/j.intimp.2017.06.017_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/13880209.2015.1029052","article-title":"Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes","volume":"54","author":"Zhang","year":"2016","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2017.06.017_bb0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"issue":"24","key":"10.1016\/j.intimp.2017.06.017_bb0155","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1016\/j.bmc.2005.07.076","article-title":"Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis","volume":"13","author":"Hu","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2017.06.017_bb0160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C","article-title":"Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes","volume":"44","author":"Tetlow","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2017.06.017_bb0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","article-title":"Matrix metalloproteinases: they're not just for matrix anymore!","volume":"13","author":"McCawley","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2017.06.017_bb0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/138945010791011938","article-title":"NF-\u03baB signaling: multiple angles to target OA","volume":"11","author":"Marcu","year":"2010","journal-title":"Curr. Drug Targets"},{"issue":"11","key":"10.1016\/j.intimp.2017.06.017_bb0180","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","article-title":"The NF-\u03baB signalling pathway in osteoarthritis","volume":"45","author":"Rigoglou","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2017.06.017_bb0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexcr.2016.10.014","article-title":"Overexpression of HMGB1 A-box reduced IL-1\u03b2-induced MMP expression and the production of inflammatory mediators in human chondrocytes","volume":"349","author":"Fu","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.intimp.2017.06.017_bb0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.joca.2005.10.009","article-title":"NF-\u03baBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1\u03b2-induced and TNF-\u03b1-induced chondrocytes","volume":"14","author":"Lianxu","year":"2006","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.intimp.2017.06.017_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0945-053X(02)00007-0","article-title":"Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-\u03baB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes","volume":"21","author":"Liacini","year":"2002","journal-title":"Matrix Biol."},{"key":"10.1016\/j.intimp.2017.06.017_bb0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ejphar.2013.10.019","article-title":"Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice","volume":"723","author":"Tang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2017.06.017_bb0205","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bcp.2013.01.020","article-title":"Gastrodin attenuation of the inflammatory response in H9c2 cardiomyocytes involves inhibition of NF-\u03baB and MAPKs activation via the phosphatidylinositol 3-kinase signaling","volume":"85","author":"Yang","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2017.06.017_bb0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bcp.2012.04.020","article-title":"Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-\u03baB and MAPK pathways","volume":"84","author":"Joh","year":"2012","journal-title":"Biochem. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917302394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917302394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:08:36Z","timestamp":1761584916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917302394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"alternative-id":["S1567576917302394"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.06.017","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptotanshinone protects against IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}